Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: October 2020

MissionIRNewsBreaks – 180 Life Sciences Corp. Announces New Board Appointments

Posted on October 5, 2020 by MissionIR

KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a clinical-stage biotechnology company, recently announced … Continue reading →

Posted in 180 Life Sciences Corp., KBL Merger Corp. IV KBLM | Leave a comment

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials

Posted on October 5, 2020 by MissionIR

Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy

Posted on October 5, 2020 by MissionIR

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively … Continue reading →

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Appoints Digital Media Exec as BIGtoken CEO

Posted on October 5, 2020 by MissionIR

SRAX (NASDAQ: SRAX), a financial technology solutions provider, today announced that one of its board members, Malcolm CasSelle, will be appointed chief executive officer of BIGtoken, a wholly owned subsidiary of SRAX. In addition to his seven-year tenure on SRAX’s … Continue reading →

Posted in MissionIRNewsBreaks, SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Issues Update on Non-Compliance with Nasdaq Listing Requirements

Posted on October 5, 2020 by MissionIR

Youngevity International (NASDAQ: YGYI), a leading multichannel lifestyle company operating in three distinct business segments, on Friday announced its receipt of a September 29, 2020, Staff Determination Letter (the “September Notification”) from the Listing Qualifications Department of the Nasdaq Stock … Continue reading →

Posted in MissionIRNewsBreaks, Youngevity International Inc. YGYI | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform

Posted on October 2, 2020 by MissionIR

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which thrives on its business-to-business (“B2B”) … Continue reading →

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Cybin Corp. CEO Eyes Opportunity in Psychedelics Space, Organic IP Expansion

Posted on October 2, 2020 by MissionIR

Cybin Corp., a Canada-based, life-science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, recently announced the appointment of Doug Drysdale as the company’s chief executive officer. Well recognized in the pharmaceutical space, Drysdale brings more than three decades of … Continue reading →

Posted in Cybin Corp. | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics CIO Discusses Convergence of AI, Data and Biology on DojoLIVE!

Posted on October 2, 2020 by MissionIR

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, was featured in a recent article discussing the appearance of one of its executives, Helomics CIO Mark Collins, PhD, on DojoLIVE! (https://ibn.fm/Y9fBZ). … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – 180 Life Sciences Corp. Setting the Stage for Success in Bringing Novel Products to Market

Posted on October 2, 2020 by MissionIR

180 Life Sciences, a clinical-stage biotechnology company, is focused on research to solve one of the world’s most significant drivers of disease – inflammation. The company currently has three programs for the development of novel drugs in the areas of … Continue reading →

Posted in 180 Life Sciences Corp., KBL Merger Corp. IV KBLM | Leave a comment

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Applauds President Trump’s Bold Action to Address Threat of Foreign Reliance on Critical Minerals

Posted on October 2, 2020 by MissionIR

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium and vanadium in the United States, on Thursday announced that President Trump issued an Executive Order on Addressing the Threat to the Domestic Supply Chain from Reliance on … Continue reading →

Posted in Energy Fuels Inc. UUUU, MissionIRNewsBreaks | Leave a comment